# Rostein, Daniel MD SC – FDA Inspection, Apr 19, 2016

Source: https://www.keypedia.com/records/fda_inspections/rostein-daniel-md-sc/e55961af-e040-455a-a98e-bd632d8b9e42
Source feed: FDA_Inspections

> FDA inspection 968484 of Rostein, Daniel MD SC, April 19, 2016. Classification: No Action Indicated (NAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 968484
- Company Name: Rostein, Daniel MD SC
- Inspection Date: 2016-04-19
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1275789 - 2025-07-14
- FDA Inspection 1217487 - 2023-09-11
- FDA Inspection 1061629 - 2018-07-19
- FDA Inspection 888990 - 2014-06-30

Company: https://www.keypedia.com/companies/rostein-daniel-md-sc/0461572e-437c-4af5-9352-48169f8b2b77

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d